Position in PFE
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$21,323,053
+$3,318,386 QoQ
Shares Held
759,368
+5.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 90.21409909292991.ToString("F0")%
Shared 0.ToString("F0")%
None 9.78590090707009.ToString("F0")%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CAPITAL INTERNATIONAL SARL holds $415,680,689 across 10 Drug Manufacturers - General names. PFE ranks #5 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
914,752 | $180,407,389 | |
| 2 | LLY |
ELI LILLY & Co
|
150,461 | $138,389,513 | |
| 3 | AMGN |
Amgen Inc
|
94,516 | $33,255,454 | |
| 4 | ABBV |
AbbVie Inc.
|
108,363 | $23,567,868 | |
| 5 | PFE |
Pfizer Inc
This page
|
759,368 | $21,323,053 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
94,231 | $5,715,110 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
40,000 | $5,574,800 | |
| 8 | GRFS |
Grifols SA
|
645,251 | $5,174,913 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,323,053 | 759,368 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $18,004,667 | 723,079 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $10,666,310 | 418,615 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $9,540,476 | 393,584 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $9,781,442 | 386,008 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $9,457,334 | 356,477 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $9,954,839 | 343,982 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $8,289,494 | 296,265 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $7,023,691 | 253,106 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $12,613,993 | 438,138 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $13,298,018 | 400,905 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $13,820,290 | 376,780 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $14,333,978 | 351,323 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $14,780,434 | 288,455 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $10,880,792 | 248,647 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $10,159,990 | 193,782 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $8,591,593 | 165,957 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $5,194,097 | 87,961 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $758,696 | 17,640 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $732,566 | 18,707 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,022,012 | 28,209 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,180,607 | 32,073 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $945,807 | 27,163 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $562,757 | 18,139 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $397,625 | 12,840 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||